Prognostic Significance of SPARC Expression in Breast Cancer: A Meta-Analysis and Bioinformatics Analysis
- PMID: 35211625
- PMCID: PMC8863438
- DOI: 10.1155/2022/8600419
Prognostic Significance of SPARC Expression in Breast Cancer: A Meta-Analysis and Bioinformatics Analysis
Abstract
Secreted protein, acidic and rich in cysteine (SPARC, also known as osteonectin), is a small molecule glycoprotein associated with cell secretions. The purpose of our research is to clarify the clinicopathological and prognostic significance of SPARC expression in breast cancer. In this study, we performed a meta-analysis and bioinformatics analysis using the PubMed, Web of Science, Wanfang Data, and CNKI databases. The meta-analysis showed that SPARC expression was elevated in breast cancer tissue, compared with normal tissue, while SPARC expression in tumor stromal cells was higher than that of tumor cells. The expression of SPARC was positively correlated with histological grade and TNM staging. The Kaplan-Meier plotter showed that low SPARC expression was negatively correlated with the overall, postprogression, and distant metastasis survival rates of patients. According to Oncomine database, SPARC expression was upregulated in breast cancer than normal tissues. In TCGA database, univariate analysis showed that lymph node metastasis, distant metastasis, and TNM staging were negatively correlated with patient prognosis in breast cancers. Cox multivariate analysis showed that age, lymph node metastasis, distant metastasis, and TNM staging were important factors affecting the survival time of breast cancer patients. SPARC expression can be employed as a good indicator of prognosis of breast cancer patients, which will provide new methods and ideas of preventive treatment.
Copyright © 2022 Shuai Shi et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8863438/bin/BMRI2022-8600419.001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8863438/bin/BMRI2022-8600419.002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8863438/bin/BMRI2022-8600419.003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8863438/bin/BMRI2022-8600419.004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8863438/bin/BMRI2022-8600419.005.gif)
Similar articles
-
Clinicopathological and prognostic significance of SPARC expression in gastric cancer: A meta‑analysis and bioinformatics analysis.Oncol Lett. 2023 Apr 20;25(6):240. doi: 10.3892/ol.2023.13826. eCollection 2023 Jun. Oncol Lett. 2023. PMID: 37181948 Free PMC article.
-
Prognostic significance of SPARC expression in non-small cell lung cancer: A meta-analysis and bioinformatics analysis.Oncol Lett. 2022 Sep 27;24(5):412. doi: 10.3892/ol.2022.13532. eCollection 2022 Nov. Oncol Lett. 2022. PMID: 36245823 Free PMC article.
-
Prognostic role of SPARC expression in gastric cancer: a meta-analysis.Arch Med Sci. 2014 Oct 27;10(5):863-9. doi: 10.5114/aoms.2014.46207. Epub 2014 Oct 23. Arch Med Sci. 2014. PMID: 25395936 Free PMC article. Review.
-
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.Breast Cancer Res Treat. 2011 Feb;126(1):1-14. doi: 10.1007/s10549-010-0867-2. Epub 2010 Apr 6. Breast Cancer Res Treat. 2011. PMID: 20369286
-
A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire.J Cell Biochem. 2008 Jun 1;104(3):721-32. doi: 10.1002/jcb.21688. J Cell Biochem. 2008. PMID: 18253934 Review.
Cited by
-
Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond.Cancers (Basel). 2024 Jan 22;16(2):466. doi: 10.3390/cancers16020466. Cancers (Basel). 2024. PMID: 38275906 Free PMC article. Review.
-
Hic-5 regulates extracellular matrix-associated gene expression and cytokine secretion in cancer associated fibroblasts.Exp Cell Res. 2024 Feb 15;435(2):113930. doi: 10.1016/j.yexcr.2024.113930. Epub 2024 Jan 17. Exp Cell Res. 2024. PMID: 38237846 Free PMC article.
-
Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients.Biomedicines. 2023 Dec 6;11(12):3231. doi: 10.3390/biomedicines11123231. Biomedicines. 2023. PMID: 38137452 Free PMC article.
-
SPARC: a potential target for functional nanomaterials and drugs.Front Mol Biosci. 2023 Jul 28;10:1235428. doi: 10.3389/fmolb.2023.1235428. eCollection 2023. Front Mol Biosci. 2023. PMID: 37577749 Free PMC article. Review.
-
Omics Overview of the SPARC Gene in Mesothelioma.Biomolecules. 2023 Jul 11;13(7):1103. doi: 10.3390/biom13071103. Biomolecules. 2023. PMID: 37509139 Free PMC article. Review.
References
-
- Wang W. J., Mei C. L. Research progress of SPARC. Chinese Journal of Clinical Medicine . 2004;5:65–68.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous